Search research articles
Contact Us
Filters
Showing results (21-30 of 129) with videos related to
Page
of 13
Sort By:
Recent Patents on Anti-Cancer Drug Discovery
|
January 29, 2008
Recent developments to improve the efficacy of cytotoxic nucleoside analogues
Lars P Jordheim, Carlos M Galmarini, Charles Dumontet
International Archives of Allergy and Applied Immunology
|
January 1, 1972
Antibody response to phytohaemagglutinin in rats
B Pacheco-Rupil, C Yantorno, M Galmarini
Current Medicinal Chemistry
|
May 14, 2008
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy
C M Galmarini, F Popowycz, B Joseph
Expert Review of Anticancer Therapy
|
November 6, 2003
Pyrimidine nucleoside analogs in cancer treatment
Carlos M Galmarini, Lars Jordheim, Charles Dumontet
Marine Drugs
|
January 30, 2014
Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment
Carlos M Galmarini, Maurizio D'Incalci, Paola Allavena
Leukemia & Lymphoma
|
August 15, 2003
Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies
Carlos M Galmarini, Lars Jordheim, Charles Dumontet
Journal of Dental Research
|
November 1, 1972
Localization of immunoglobulin A in electrophoretic patterns of proteins from human parotid saliva
S L Bellavia, M Galmarini, C Yantorno
American Journal of Reproductive Immunology and Microbiology : AJRIM
|
August 1, 1986
Adoptive transfer of suppression of autoimmune response to rat male accessory glands with spleen mononuclear cells from antigen-pretreated rats
M E Ferro, M Galmarini, C M Riera
Leukemia
|
June 22, 2001
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
C M Galmarini, J R Mackey, C Dumontet
Immunology Letters
|
January 1, 1983
Evaluation of the immunosuppression in an experimental model of autoimmunity: suppressor activity of spleen cells from cyclophosphamide-treated rats
H M Serra, M Galmarini, C M Riera
Page
of 13
Search research articles
Search
Showing results (21-30 of 129) with videos related to
Sort By:
Page
of 13
Recent Patents on Anti-Cancer Drug Discovery
|
January 29, 2008
Recent developments to improve the efficacy of cytotoxic nucleoside analogues
Lars P Jordheim, Carlos M Galmarini, Charles Dumontet
International Archives of Allergy and Applied Immunology
|
January 1, 1972
Antibody response to phytohaemagglutinin in rats
B Pacheco-Rupil, C Yantorno, M Galmarini
Current Medicinal Chemistry
|
May 14, 2008
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy
C M Galmarini, F Popowycz, B Joseph
Expert Review of Anticancer Therapy
|
November 6, 2003
Pyrimidine nucleoside analogs in cancer treatment
Carlos M Galmarini, Lars Jordheim, Charles Dumontet
Marine Drugs
|
January 30, 2014
Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment
Carlos M Galmarini, Maurizio D'Incalci, Paola Allavena
Leukemia & Lymphoma
|
August 15, 2003
Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies
Carlos M Galmarini, Lars Jordheim, Charles Dumontet
Journal of Dental Research
|
November 1, 1972
Localization of immunoglobulin A in electrophoretic patterns of proteins from human parotid saliva
S L Bellavia, M Galmarini, C Yantorno
American Journal of Reproductive Immunology and Microbiology : AJRIM
|
August 1, 1986
Adoptive transfer of suppression of autoimmune response to rat male accessory glands with spleen mononuclear cells from antigen-pretreated rats
M E Ferro, M Galmarini, C M Riera
Leukemia
|
June 22, 2001
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
C M Galmarini, J R Mackey, C Dumontet
Immunology Letters
|
January 1, 1983
Evaluation of the immunosuppression in an experimental model of autoimmunity: suppressor activity of spleen cells from cyclophosphamide-treated rats
H M Serra, M Galmarini, C M Riera
Page
of 13